These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 36344703)
1. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics. Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703 [TBL] [Abstract][Full Text] [Related]
2. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases. Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219 [TBL] [Abstract][Full Text] [Related]
3. Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review. Li SY; Zhang HL; Bai YZ Pediatr Hematol Oncol; 2021 Sep; 38(6):602-608. PubMed ID: 33792506 [TBL] [Abstract][Full Text] [Related]
4. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases. Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642 [TBL] [Abstract][Full Text] [Related]
5. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity. Zhao M; Yin X; He H; Fan Y; Ru G; Meng X Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381 [TBL] [Abstract][Full Text] [Related]
6. Case of recurrent superficial CD34-positive fibroblastic tumor. Salah HT; D'Ardis JA; Baek D; Duran J; Schwartz MR; Ayala AG; Ro JY J Cutan Pathol; 2023 Jun; 50(6):477-480. PubMed ID: 36107756 [TBL] [Abstract][Full Text] [Related]
7. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor. Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957 [TBL] [Abstract][Full Text] [Related]
8. A case of superficial CD34 positive fibroblastic tumor: Diagnostic challenges and pitfalls. Dey S; Chatterjee U Indian J Pathol Microbiol; 2024 Jul; 67(3):658-660. PubMed ID: 38391337 [TBL] [Abstract][Full Text] [Related]
9. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features. Salah HT; D'ardis JA; Baek D; Schwartz MR; Ayala AG; Ro JY Ann Diagn Pathol; 2022 Jun; 58():151937. PubMed ID: 35344860 [TBL] [Abstract][Full Text] [Related]
10. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study. Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036 [TBL] [Abstract][Full Text] [Related]
11. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications. Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762 [TBL] [Abstract][Full Text] [Related]
12. Superficial CD34-Positive Fibroblastic Tumor. Foot O; Hallin M; Bagué S; Jones RL; Thway K Int J Surg Pathol; 2020 Dec; 28(8):879-881. PubMed ID: 32608310 [TBL] [Abstract][Full Text] [Related]
13. Superficial CD34-Positive Fibroblastic Tumor: A Newly Recognized Entity With Overlapping Features of PRDM10-Rearranged Soft Tissue Tumors. Shaker N; Abu Shakra R; Sangueza OP Cureus; 2023 Oct; 15(10):e47831. PubMed ID: 38021590 [TBL] [Abstract][Full Text] [Related]
14. Superficial CD34 Sun J; Huang S; Yang X Oncol Lett; 2024 Jul; 28(1):335. PubMed ID: 38827569 [TBL] [Abstract][Full Text] [Related]
18. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity. Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209 [TBL] [Abstract][Full Text] [Related]
19. Superficial CD34-positive fibroblastic tumor in the forearm of a middle-aged patient: A newly described, rare soft-tissue tumor. Rekhi B; Banerjee D; Gala K; Gulia A Indian J Pathol Microbiol; 2018; 61(3):421-424. PubMed ID: 30004071 [TBL] [Abstract][Full Text] [Related]